Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses - ScienceDirect
Low Levels of Complement Factor C4 Not Always Implicate Disease Activity in Systemic Lupus Erythematosus
The impact of normal serum complement levels on the disease classification and clinical characteristics in systemic lupus erythematosus | Advances in Rheumatology | Full Text
Biomolecules | Free Full-Text | Complement as a Biomarker for Systemic Lupus Erythematosus
Values of CH50, complement proteins C3, C4, C3d and circulating immune... | Download Table
Anyone with CH50 high, but normal C3, C4? : r/Autoimmune
![PDF] Alternative Pathway of Complement Activation in Full Term and Premature Infants | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a850c81b9699473fa6507343277b903b4c659cf5/2-Table1-1.png "PDF] Alternative Pathway of Complement Activation in Full Term and Premature Infants | Semantic Scholar")
PDF] Alternative Pathway of Complement Activation in Full Term and Premature Infants | Semantic Scholar
Low Levels of Complement Factor C4 Not Always Implicate Disease Activity in Systemic Lupus Erythematosus
Anyone with CH50 high, but normal C3, C4? : r/Autoimmune
CH50 Levels and Concomitant | Download Table
Complement
Serum Complement Levels in Immune Thrombocytopenia: Relation with Clinical Presentation and Treatment Response - ISTH Congress Abstracts
Clinical and Experimental Pediatrics
Novel pathogenic mutations identified in the first Chinese pedigree of complete C6 deficiency - Li - 2020 - Clinical & Translational Immunology - Wiley Online Library
Frontiers | Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient
CH 50 Test | Complement Total (CH50) Blood Test | Personalabs
Table I from The complement system in renal homograft recipents. | Semantic Scholar
Complement CH50 Test (33 points) Results CH50 Kit Lot | Chegg.com
Frontiers | Interpretation of Serological Complement Biomarkers in Disease
Patients with Covid 19 have significantly reduced CH50 activity | VirusDisease
Complement component levels in percentage of normal and the CH50 in the... | Download Scientific Diagram
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation - ScienceDirect
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic
Clinical and Experimental Pediatrics
